Remove Article Remove Performance Fees Remove Return On Investment
article thumbnail

Teladoc Health (TDOC) Q2 2024 Earnings Call Transcript

The Motley Fool

We are looking thoughtfully into the modalities each step of what we do to implement and execute this with precision, with rigor, and to make sure that from an investment standpoint, we are getting the appropriate return on investments that we will make in this space. Stephanie Davis -- Analyst Thanks so much. Your line is open.

article thumbnail

Evolent Health (EVH) Q2 2023 Earnings Call Transcript

The Motley Fool

While acquisitions contributed a portion of the year-over-year growth in adjusted EBITDA, we're also benefiting from a healthy mix of higher pull-through of specialty technology and services, as well as maturation of the performance we book. Seth Blackley -- Chief Executive Officer Great.

article thumbnail

CDPQ's Head of Liquid Markets Discusses Mid-Year Results

Pension Pulse

Financial reporting As at June 30, 2023, the annualized costs incurred for CDPQ’s activities, which include internal operating expenses, external management fees and transaction costs, were estimated at 55 cents per $100 of net average assets, compared with 48 cents as at December 31, 2022.